Navigation Links
WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2012 Results, Share Repurchase Program
Date:3/7/2013

CallWuXi PharmaTech senior management will host a conference call at 8:00 am (U.S. Eastern) / 5:00 am (U.S. Pacific) / 9:00 pm (Beijing/Shanghai/Hong Kong) on Friday, March 8, 2013, to discuss its fourth-quarter and full-year 2012 financial results and future prospects.  The conference call may be accessed by calling:

United States:

1-866-519-4004China (Landline):800-819-0121China (Mobile):

400-620-8038Hong Kong:

800-930-346United Kingdom:0-808-234-6646International:+65-6723-9381Conference ID:99349171A telephone replay will be available two hours after the call's completion at:

United States:

1-855-452-5696China (Landline):800-870-0205China (Mobile):

400-120-0932Hong Kong:

800-963-117United Kingdom:0-808-234-0072International:+61-2-8199-0299Conference ID:99349171A live webcast of the conference call and replay will be available on the investor relations page of WuXi PharmaTech's website at http://www.wuxiapptec.com.

About WuXi PharmaTechWuXi PharmaTech is a leading pharmaceutical, biotechnology, and medical device R&D outsourcing company, with operations in China and the United States.  As a research-driven and customer-focused company, WuXi PharmaTech provides a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process.  WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D.  WuXi PharmaTech's operating subsidiaries are known as WuXi AppTec.  For more information, please visit: http://www.wuxiapptec.com.

Use of Non-GAAP and Pro-Forma Financial Measures  We have provided the fourth-quarter and full-year 2011 and 2012 gross profit, gross margin, operating income, operating margin, net income, net marg
'/>"/>

SOURCE Wuxi PharmaTech Co. Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. WuXi PharmaTech and Open Monoclonal Technology Expand Human Antibody Development and Commercial Opportunities for Asian Regional and Global Pharmaceutical Companies
2. WuXi PharmaTech Schedules Fourth-Quarter 2012 Earnings Release
3. WuXi PharmaTech Presents the 2012 Life Science and Chemistry Awards
4. WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2012 Annual General Meeting
5. WuXi PharmaTech Celebrates Dr. Joseph Vaccas Induction into American Chemical Societys Medicinal Chemistry Hall of Fame
6. WuXi PharmaTech and Open Monoclonal Technology Announce OmniRat(TM) Antibody Collaboration
7. WuXi PharmaTech to Manufacture Ibalizumab for TaiMed Biologics
8. WuXi PharmaTech Receives GLP Certificate from SFDA for Suzhou Toxicology Facility
9. WuXi PharmaTech Announces Second-Quarter 2012 Results
10. Pharmatech Oncology Receives Phase 2 SBIR Funding for Just-In-Time Enrollment Model
11. WuXi PharmaTech Announces First-Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... MONTREAL , Nov. 24, 2014 /PRNewswire/ - Milestone ... clinical trial conducted in Melbourne, Australia ... antagonist for the potential treatment of paroxysmal supraventricular ... formulation of MSP-2017 was well tolerated at single ... an excellent safety profile, desirable PK properties including ...
(Date:11/24/2014)... YORK , Nov. 24, 2014  Relmada Therapeutics, ... for the treatment of chronic pain, announced today that ... to present at the LD MICRO "MAIN Event" Micro-Cap ... will be held at the Luxe Sunset Bel Air ... Los Angeles, California . ...
(Date:11/24/2014)... , Nov. 24, 2014  Surgical Theater, LLC, announced ... November 24 th opening of Europe,s ... Neurologico Nazionale "C. Besta." The SuRgical Planner (SRP) and ... at the event for their 3D navigation and augmented ... Joshua Bederson , Professor and Chair, Department of Neurosurgery ...
Breaking Medicine Technology:Milestone Announces Positive Phase 1 Data for MSP-2017; Supports Advancement into Phase 2 in PSVT Patients 2Milestone Announces Positive Phase 1 Data for MSP-2017; Supports Advancement into Phase 2 in PSVT Patients 3Relmada Therapeutics To Present At LD MICRO Conference 2Surgical Theater's Technology to be Showcased at the Opening of the Besta NeuroSim Center in Milan, Italy 2Surgical Theater's Technology to be Showcased at the Opening of the Besta NeuroSim Center in Milan, Italy 3
... Biogen Idec (NASDAQ: BIIB),and Elan Corporation, plc (NYSE: ... Prescribing Program(TM) and TYGRIS safety study,confirm the safety ... presented at the 59th annual meeting,of the American ... data that showed that TYSABRI has a sustained ...
... WIRE)--May 3, 2007 - Insmed Inc.,(Nasdaq:INSM) today announced ... the company's drug, IPLEX(TM), in,patients with myotonic muscular ... being conducted at,the University of Rochester School of ... with doses of IPLEX up to 1,mg/kg/day in ...
Cached Medicine Technology:Data Presented at the American Academy of Neurology's Annual,Meeting Provide Update on Utilization and Safety of Tysabri in,Patients with Multiple Sclerosis 2Data Presented at the American Academy of Neurology's Annual,Meeting Provide Update on Utilization and Safety of Tysabri in,Patients with Multiple Sclerosis 3Data Presented at the American Academy of Neurology's Annual,Meeting Provide Update on Utilization and Safety of Tysabri in,Patients with Multiple Sclerosis 4Data Presented at the American Academy of Neurology's Annual,Meeting Provide Update on Utilization and Safety of Tysabri in,Patients with Multiple Sclerosis 5Data Presented at the American Academy of Neurology's Annual,Meeting Provide Update on Utilization and Safety of Tysabri in,Patients with Multiple Sclerosis 6Insmed Announces Promising Results From IPLEX Phase II Myotonic,Muscular Dystrophy Clinical Study 2Insmed Announces Promising Results From IPLEX Phase II Myotonic,Muscular Dystrophy Clinical Study 3Insmed Announces Promising Results From IPLEX Phase II Myotonic,Muscular Dystrophy Clinical Study 4
(Date:11/26/2014)... For its December issue , Atlantic ... on Blue Cross and Blue Shield Plans* interviewed officials ... strategies the two Blues plans are implementing in order ... sleep apnea, ranging from brick-and-mortar retail stores to patient ... increased rates of a variety of serious disorders, including ...
(Date:11/26/2014)... Howell, NJ (PRWEB) November 26, 2014 ... issues,” and Florida-based SeniorNet, a nonprofit organization providing the ... have teamed up to help seniors navigate the rough ... will focus on educating seniors on the topic of ... through the somewhat complicated process of applying for this ...
(Date:11/26/2014)... Angeles, California (PRWEB) November 26, 2014 ... score of 3.9 out of 5. This score represents ... over the three years to 2014 as a result ... for medical suction machines, which are largely considered nondiscretionary. ... the purchasing process, buyers have some degree of flexibility, ...
(Date:11/26/2014)... Sonoran Vein and Endovascular nurse, ... Distinguished Preceptorship Award from The American Association ... the advancement of nurse practitioners. The Distinguished Preceptorship ... had made a significant contribution toward increasing the ... of Nurse Practitioners (AANP) is the largest full-service ...
(Date:11/26/2014)... 25, 2014 (HealthDay News) -- The number of emergency department ... in 2010 to a record 136 million in 2011, according ... The findings also showed that fewer people were going to ... identified as needing medical care within two hours of arriving ... according to the research. Sixty percent of patients arrived ...
Breaking Medicine News(10 mins):Health News:AIS Newsletter Reports on Strategies Blues Plans Are Implementing to Combat Sleep Apnea 2Health News:AIS Newsletter Reports on Strategies Blues Plans Are Implementing to Combat Sleep Apnea 3Health News:Senior Planning Services Teams Up with SeniorNet To Educate Seniors On Medicaid Planning 2Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 4Health News:Sonoran Nurse Receives Distinguished Preceptorship Award from The American Association of Nurse Practitioners 2Health News:ER Visits on the Rise, Study Reports 2
... Nov. 12 You,re visiting the dentist for what you ... she says you need a root canal. Though it,s a ... in the chair, you may have several questions and feel ... root canals for quite some time. The Pennsylvania Dental Association ...
... Healthcare is an industry faced with unprecedented uncertainty. ... overcome the noise and clearly communicate relevant and timely ... company Griffin York & Krause (GY&K) reaffirmed its commitment ... been honored with six national CardioVascular Advertising (CVA) Awards. ...
... certification pilot significantly expands chemical emissions and content ... from products used in multiple environments. ... (GEI) announces the launch of GREENGUARD Premier(SM), a ... indoor air quality criteria, additional chemical emission requirements ...
... 12 /PRNewswire-FirstCall/ -- Mesa Laboratories, Inc. (Nasdaq: ... declared a regular quarterly dividend of $.11 per share of ... The dividend will be payable December 15, 2009, to shareholders ... in 1984 Mesa Labs has maintained strong cash positions and ...
... Christiana Care Health System,s Helen F. Graham ... nation to submit specimens to the Biospecimen Core Resource ... project is part of a sweeping initiative by the ... and even prevent cancer in the future. , ...
... holds hope of better treatment for muscular dystrophy, ... Researchers are reporting that injections of genes into the ... size and strength without side effects. , The ... gene-therapy findings, though preliminary, might someday lead to better ...
Cached Medicine News:Health News:Painful Root Canals Are a Thing of the Past 2Health News:Healthcare Organizations Face Tough Marketing Challenges - GY&K Asks 'Are You Relevant?' 2Health News:Healthcare Organizations Face Tough Marketing Challenges - GY&K Asks 'Are You Relevant?' 3Health News:GREENGUARD Launches Comprehensive Health-Based Certification Pilot Program 2Health News:Christiana Care First Community Hospital to Submit Samples to Cancer Genome Atlas Project 2
The Lang Stereotest was created to simplify stereopsis screening in children. It is based on two principles: random dots and cylindrical gratings. The Lang Stereotest I measures disparities: Star 600...
8 X 1 Red Filter. Color Filters are designed to filter out all other color regions of the visible spectrum except the specified color. Color Filters are excellent for contrast enhancement and color r...
Maxi-Lite diagnostic penlight features a twist-on backswitch....
Features a twist-on backswitch with a diffused, cobalt blue, light beam. Packaged with fluorescein strips....
Medicine Products: